Furthermore, carnosic acid which has been suggested as a potential treatment for obesity and nonalcoholic fatty liver disease has showed increased CYP2B6 enzyme activity thus indicating a potential drug interaction with carnosic acid [43]. The gene discussed is CYP2B6; the disease is obesity due to melanocortin 4 receptor deficiency.